NCT03067415View on ClinicalTrials.gov

Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily

PHASE2UnknownINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

March 30, 2017

Primary Completion Date

September 10, 2017

Study Completion Date

September 30, 2017

Conditions
Glaucoma, Primary Open AngleOcular Hypertension
Interventions
DRUG

D565H(Latanoprost 25㎍/㎖)

D565H twice daily

DRUG

D565(Latanoprost 50㎍/㎖)

D565 once daily

Trial Locations (1)

Unknown

RECRUITING

Seoul National University Hosipital, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT03067415 - Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily | Biotech Hunter | Biotech Hunter